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We read with interest the article by Nascimento and 
colleagues [1] on fresh frozen plasma (FFP) in massive 
bleedings. We fully agree with their conclusion when they 
say that we need immediately available universal donor 
AB plasma.
Hemorrhagic shock is the primary cause of avoidable 
mortality in combatants. Data from the recent US army 
war experience show clearly that in cases of massive 
transfusion the transfusion policy strongly impacts 
mortality. Namely, for massive bleeding the ratio between 
red blood cells and clotting factors should be close to the 
composition of whole blood [2].
Plasma is thus essential for massive transfusions. But 
FFP use is impractical in uncertain environments such as 
a battleﬁ   eld. During military operations, refrigerated 
transportation and storage are logistical problems. 
Th   awing of FFP takes a long time, with an important loss 
of plasma in austere environments. For example, Mabry 
and colleagues [3] report that, during the Mogadishu 
urban battle, the available FFP was stored in bags that 
fractured one-third of the time upon thawing.
For these reasons, the French army has used freeze-
dried and secured plasma (FDSP) since 1994. Plasma 
separated from fresh blood of at least ten donors is 
lyophilized to produce FSDP. Blood type selection allows 
the dilution and neutralization of natural anti-A and anti-
B hemagglutinins. Th   is FDSP is thus compatible with any 
blood type. In addition, FDSP is shelf-stable in ambient 
temperatures for 2 years and easily rehydrated with 
200  ml of water for injections in less than 3 minutes, 
allowing immediate provision with the ﬁ  rst packed red 
blood cells [4].
FDSP contains all clotting factors and proteins. After 
more than 2 years storage at ambient temperature, the 
ﬁ   brinogen and clotting factor levels of FDSP are 
equivalent to FFP [4].
Th   e securization process is quarantine (i.e. the plasma is 
held until the donor returns and is retested after a period 
that is longer than the window period of known viruses). 
Plasma as FDSP is thus a logistically superior product, 
without compromising hemostatic properties, quickly 
available in cases of emergency for any blood type.
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Bartolomeu Nascimento Jr, Jeannie Callum and Sandro B Rizoli
We thank Daban and colleagues for their insightful 
obser  vations and agree with the comments on the 
challenges to using AB FFP in trauma. Products such as 
freeze-dried plasma or lyophilized plasma are appealing 
for trauma resuscitation since they have many of the 
characteristics of an ideal resuscitation ﬂ  uid for bleeding/
coagulopathic patients. Such an ideal ﬂ  uid would be easy 
to prepare and rapid to administer, contain all clotting 
factors, not require blood typing and matching, be free of 
infectious and immunological risks and have a long shelf 
life. Concerning volume, it is unclear whether the beneﬁ  t 
of early and aggressive FFP transfusion in massive 
traumatic bleeding is related to either clotting factor or 
volume replacement with reduced crystalloid exposure. 
Since most trauma patients are hypovolemic, large 
volumes are often advantageous, but in circumstances 
where circulatory overload is a concern, the use of small 
volume clotting factor concentrates, including freeze-
dried plasma, would be superior.
We lack experience with lyophilized plasma, which to 
our knowledge is available only to military personnel of 
some countries. Historically it was implicated in hepatitis 
epidemics during the Korean War, but safer preparations 
are now available and the interest in this product is 
growing, particularly over the past few years. Recent 
experience with this product comes from the battleﬁ  eld, 
but mostly from animal models [4-6], in which lyo-
philized plasma was found to be equivalent to FFP in 
correcting coagulopathy [5,6]. We agree that further 
clinical studies with this product are needed.
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